Literature DB >> 23921730

Trials challenging HIV drug doses could usher in huge cost cuts.

Monica Heger.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23921730     DOI： 10.1038/nm0813-953

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  2 in total

Review 1.  Optimizing HIV treatment.

Authors:  Andrew Hill
Journal:  Curr Opin HIV AIDS       Date:  2013-01       Impact factor: 4.283

2.  Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.

Authors:  P A Volberding; S W Lagakos; M A Koch; C Pettinelli; M W Myers; D K Booth; H H Balfour; R C Reichman; J A Bartlett; M S Hirsch
Journal:  N Engl J Med       Date:  1990-04-05       Impact factor: 91.245
  2 in total
  2 in total

1.  Finding the right chemistry.

Authors:  Killugudi Jayaraman
Journal:  Nat Med       Date:  2013-10       Impact factor: 53.440

2.  The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.

Authors:  Arin Dutta; Catherine Barker; Ashley Kallarakal
Journal:  PLoS Med       Date:  2015-11-24       Impact factor: 11.069
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.